StockData
Palisade Bio, Inc. logo

Palisade Bio, Inc. (PALI) stock

PALINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/30
$1.01−0.02 (-1.94%)

Close on Nov 17, 2026Market cap $176.01MP/E –Yield –

Palisade Bio total assets

Total assets on the balance sheet at the end of each period.

Palisade Bio's total assets was $127.32M at Jun 30, 2026. For fiscal 2025 it was $134.34M, up 1134.8% from the year before. Over ten years it grew 24.6% a year on average. The highest annual figure on record is $134.34M in fiscal 2025.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$134.34M+1134.8%
FY2024Dec 31, 2024$10.88M-22.6%
FY2023Dec 31, 2023$14.05M-10.9%
FY2022Dec 31, 2022$15.76M+26.0%
FY2021Dec 31, 2021$12.51M+314.4%
FY2020Dec 31, 2020$3.02M-54.1%
FY2019Dec 31, 2019$6.58M-14.3%
FY2018Dec 31, 2018$7.68M-44.7%
FY2017Dec 31, 2017$13.88M-38.6%
FY2016Dec 31, 2016$22.60M+51.2%
FY2015Dec 31, 2015$14.95M-49.9%
FY2014Dec 31, 2014$29.84M+53.7%
FY2013Dec 31, 2013$19.41M+121.9%
FY2012Dec 31, 2012$8.75M+114.1%
FY2011Dec 31, 2011$4.09M-61.4%
FY2010Dec 31, 2010$10.59M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$127.32M+1809.6%
Q1 FY2026Mar 31, 2026$133.32M+1527.8%
Q4 FY2025Dec 31, 2025$134.34M+1134.8%
Q3 FY2025Sep 30, 2025$6.97M-25.3%
Q2 FY2025Jun 30, 2025$6.67M-48.2%
Q1 FY2025Mar 31, 2025$8.19M-35.3%
Q4 FY2024Dec 31, 2024$10.88M-22.6%
Q3 FY2024Sep 30, 2024$9.34M-45.3%
Q2 FY2024Jun 30, 2024$12.87M-29.6%
Q1 FY2024Mar 31, 2024$12.65M-17.1%
Q4 FY2023Dec 31, 2023$14.05M-10.9%
Q3 FY2023Sep 30, 2023$17.07M+4.9%
Q2 FY2023Jun 30, 2023$18.29M+134.3%
Q1 FY2023Mar 31, 2023$15.26M+82.8%
Q4 FY2022Dec 31, 2022$15.76M+26.0%
Q3 FY2022Sep 30, 2022$16.27M-0.0%
Q2 FY2022Jun 30, 2022$7.81M-47.8%
Q1 FY2022Mar 31, 2022$8.35M-6.3%
Q4 FY2021Dec 31, 2021$12.51M+314.4%
Q3 FY2021Sep 30, 2021$16.27M+7.3%
Q2 FY2021Jun 30, 2021$14.95M-12.6%
Q1 FY2021Mar 31, 2021$8.91M-21.5%
Q4 FY2020Dec 31, 2020$3.02M-54.1%
Q3 FY2020Sep 30, 2020$15.17M+69.6%
Q2 FY2020Jun 30, 2020$17.10M+385.6%
Q1 FY2020Mar 31, 2020$11.36M+110.2%
Q4 FY2019Dec 31, 2019$6.58M-14.3%
Q3 FY2019Sep 30, 2019$8.94M+15.8%
Q2 FY2019Jun 30, 2019$3.52M-61.9%
Q1 FY2019Mar 31, 2019$5.41M-53.2%
Q4 FY2018Dec 31, 2018$7.68M-44.7%
Q3 FY2018Sep 30, 2018$7.72M-52.3%
Q2 FY2018Jun 30, 2018$9.23M-30.4%
Q1 FY2018Mar 31, 2018$11.55M-38.3%
Q4 FY2017Dec 31, 2017$13.88M-38.6%
Q3 FY2017Sep 30, 2017$16.19M+91.6%
Q2 FY2017Jun 30, 2017$13.27M–
Q1 FY2017Mar 31, 2017$18.73M–
Q4 FY2016Dec 31, 2016$22.60M–
Q3 FY2016Sep 30, 2016$8.45M–

More Palisade Bio figures

See a number that looks wrong?